Corxel Pharmaceuticals
Clinical trials sponsored by Corxel Pharmaceuticals, explained in plain language.
-
New diabetes drug CX11 aims to tame blood sugar in phase 2 trial
Disease control Recruiting nowThis study tests a new medication, CX11, in 240 adults with type 2 diabetes whose blood sugar is not well-controlled despite taking metformin. Participants are randomly assigned to receive different doses of CX11 or a placebo pill for 24 weeks. The main goal is to see if CX11 saf…
Phase: PHASE2 • Sponsor: Corxel Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 11:50 UTC
-
New drug trial offers hope for stroke patients who miss early treatment window
Disease control Recruiting nowThis study is testing whether an experimental drug called JX10 can help people recover better from a stroke caused by a blocked blood vessel in the brain. It focuses on patients who arrive at the hospital between 4.5 and 24 hours after their stroke symptoms begin, which is later …
Phase: PHASE2, PHASE3 • Sponsor: Corxel Pharmaceuticals • Aim: Disease control
Last updated Apr 20, 2026 16:16 UTC